| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-6.33555 (Miss by $-10.57555) |
| EPS GAAP Actual | $-6.33555 (Miss by $-10.57555) |
| Revenue Actual | $6.5104B |
| Revenue Surprise | Beat by $6510.4M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 30.25 | 11.45 | 29.01207 | 31.98314 | 1 |
| Dec 2028 | 28.5 | 12.15 | 27.93547 | 29.31985 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 4.7 | 4.7 | 6.5104B | 9.86% | 6510.4M |
| FQ2 2025 (Jun 2025) | 2.36 | 2.36 | 6.2501B | 9.94% | 6250.1M |
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 5.7464B | 100% | 5746.4M |
| FQ4 2024 (Dec 2024) | 5.07 | 5.07 | 6.8109B | 100% | 6810.9M |
| FQ3 2024 (Sep 2024) | 3.26 | 3.26 | 5.8688B | 12.91% | 5868.8M |
| FQ2 2024 (Jun 2024) | 1.78 | 1.78 | 5.6287B | 10.24% | 5628.7M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0B | -INF% | 0M |
| FQ3 2023 (Sep 2023) | 1.25 | 1.25 | 5.1114B | 100% | 5111.4M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 9.7443 | -- | 9.43311 | 10.03224 | 2 |
| FQ3 2028 (Sep 2028) | 6.2591 | -- | 6.05921 | 6.44406 | 2 |
| FQ2 2028 (Jun 2028) | 5.0371 | -- | 4.87624 | 5.18595 | 2 |
| FQ1 2028 (Mar 2028) | 3.6454 | -- | 3.52898 | 3.75312 | 2 |
| FQ4 2027 (Oct 2027) | 5.2174 | -- | 5.00614 | 5.47894 | 2 |
| FQ3 2027 (Jul 2027) | 4.671 | -- | 4.48186 | 4.90515 | 2 |
| FQ2 2027 (Jun 2027) | 4.66392 | -- | 4.51497 | 4.80174 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 3.55B | -- | 3.47B | 3.63B | 1 |
| FQ3 2028 (Sep 2028) | 2.85B | -- | 2.78B | 2.91B | 1 |
| FQ2 2028 (Jun 2028) | 2.65B | -- | 2.58B | 2.71B | 1 |
| FQ1 2028 (Mar 2028) | 2.31B | -- | 2.26B | 2.37B | 1 |
| FQ4 2027 (Oct 2027) | 5.89B | -- | 5.71B | 6.12B | 2 |
| FQ3 2027 (Jul 2027) | 5.83B | -- | 5.65B | 6.06B | 2 |
| FQ2 2027 (Jun 2027) | 7.11B | -- | 6.94B | 7.28B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 4.7 | 4.7 | 100% | |
| FQ2 2025 (Jun 2025) | 2.36 | 2.36 | 100% | |
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 100% | |
| FQ4 2024 (Dec 2024) | 5.07 | 5.07 | 100% | |
| FQ3 2024 (Sep 2024) | 3.26 | 3.26 | 100% | |
| FQ2 2024 (Jun 2024) | 1.78 | 1.78 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 1.25 | 1.25 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $6.51B | $6510.4M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $6.25B | $6250.1M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $5.75B | $5746.4M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $6.81B | $6810.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $5.87B | $5868.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.63B | $5628.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $5.11B | $5111.4M | 100% |